Industry

DUBLIN–(BUSINESS WIRE)–The “Global Direct-To-Consumer Genetic Testing Market By Test Type, By Technology chips, Targeted Analysis, Whole Genome Sequencing, By Sample, By Distribution Channel, By Region Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Direct-To-Consumer (DTC) Genetic Testing Market stood at USD 1,254.69 million in 2021 and is expected to … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Onychomycosis Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. The report provides the most up-to-date information on key pipeline products within the global Onychomycosis market. It covers emerging therapies for Onychomycosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “United Kingdom Diagnostic Imaging Market, By Type (X-Ray Imaging Solutions, Ultrasound Systems, MRI Systems, CT Scanners, Others), By Mobility, By Source, By Application, By End User, By Region, Competition Forecast & Opportunities, 2017-2027” report has been added to ResearchAndMarkets.com’s offering. The United Kingdom diagnostic imaging market is projected to grow at a formidable … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Analgesics Market By Type, By Route of Administration: Global Opportunity Analysis and Industry Forecast, 2020-2030” report has been added to ResearchAndMarkets.com’s offering. The global analgesics market was valued at $26,654.4 million in 2020, and is projected to reach $50,682.6 million by 2030, registering a CAGR of 6.6% during the forecast period 2021-2030. Analgesics, … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, presented updated findings from the Phase II SUMMIT basket trial of neratinib for EGFR exon 18-mutant non-small cell lung cancer (NSCLC) patients at the EORTC/NCI/AACR Molecular Targets and Cancer Therapeutics Symposium that is taking place in Barcelona, Spain. The poster, entitled, “Neratinib efficacy in patients … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Inhalation Anesthesia Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global inhalation anesthesia market is expected to grow from $1.26 billion in 2021 to $1.35 billion in 2022 at a compound annual growth rate (CAGR) of 6.7%. The inhalation anesthesia market is expected to reach $1.68 billion in 2026 … [Read more…]

Strong Start to Fiscal Year with H1 Core Revenue Growth of +5.5% at Constant Exchange Rate (CER); Reported Revenue Growth +10.1% Core Operating Profit Growth of +14.5% at CER; Core Operating Profit Margin of 31.7% Reported Operating Profit Growth Affected by One-time Gain Booked in FY2021 Q1 from Sale of Diabetes Portfolio in Japan and … [Read more…]

SINGAPORE–(BUSINESS WIRE)–#CDMO–Prestige Biopharma group comprised of Prestige Biopharma Limited (950210: KRX) and Prestige Biologics Co., Ltd. (334970: KOSDAQ) is pleased to announce that it will be appearing at CPhI Frankfurt 2022 on 1-3 November at Messe Frankfurt, Germany. The Prestige group will showcase its latest antibody drug pipeline and innovative CDMO service at a large-scale … [Read more…]

EINDHOVEN, the Netherlands & LAUSANNE, Switzerland & BOSTON–(BUSINESS WIRE)–ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced that it will host a webcast to discuss its Q3 business highlights. The Company also provided information on its participation at … [Read more…]

LUXEMBOURG–(BUSINESS WIRE)–October marks the 35th anniversary of Eurofins (Paris:ERF). Today, the global leader in bio-analysis with 61,000 staff across a network of 940 laboratories in 59 countries, Eurofins’ growth has been characterised by its steadfast focus on long-term value creation for customers, employees and shareholders. Eurofins companies have consistently invested in research and development, start-up … [Read more…]